WG

Wanlian Guangsheng

Description

Wanlian Guangsheng is an investment firm.

Investor Profile

Wanlian Guangsheng has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Manufacturing, Biotechnology, Health Care.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • China (100%)

Industry Focus

  • Manufacturing
  • Biotechnology
  • Health Care
  • Life Science
  • Pharmaceutical
  • Optical Communication
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wanlian Guangsheng frequently co-invest with?

YIMI
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
Guangdong Technology Financial Group
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
October Capital
North America, Missouri, United States, Kansas City
Co-Investments: 1
Wanlian Tianze
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
GK
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
PI
Asia, Guangdong, China, Panyu
Co-Investments: 1
Chuangyu Investment Management
Asia, Guangdong, China, Huangpu
Co-Investments: 1
BOC & Utrust Private Equity Fund Management
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
KC
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
Addor Capital
Asia, Jiangsu, China, Nanjing
Co-Investments: 1

What are some of recent deals done by Wanlian Guangsheng?

Liobate

Guangzhou, Guangdong, China

Liobate specializes in designing, creating, and selling thin-film lithium niobate modulator chips and related optical interconnect devices.

ManufacturingOptical CommunicationSemiconductor
Series AFeb 28, 2025
Amount Raised: $13,729,097
Bostal Drug Delivery

Guangzhou, Guangdong, China

Bostal Drug Delivery develops and manufactures drug preparation products for new drug delivery systems.

BiotechnologyHealth CareLife ScienceManufacturingPharmaceutical
Series BAug 19, 2023

Find More Investors Like Wanlian Guangsheng

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Wanlian Guangsheng | Pipeseed